Chikungunya in Northwest Costa Rica
The Centers for Disease Control and Prevention (CDC) has issued a Level 2 travel health notice regarding an ongoing chikungunya outbreak in northwest Costa Rica as of July 2026.
About Chikungunya
Chikungunya is a viral illness transmitted primarily by Aedes mosquitoes (the same vectors for dengue and Zika). The disease is characterized by sudden onset of fever, joint pain, and muscle aches. While not typically fatal, chikungunya can cause debilitating joint pain that may persist for weeks to months following acute infection.
Affected Region
The current outbreak is concentrated in northwest Costa Rica. Travelers planning visits to this region should take appropriate precautions.
Prevention Recommendations
Mosquito Bite Prevention:
- Use EPA-registered insect repellents containing DEET (20-30%), picaridin (20%), IR3535, oil of lemon eucalyptus, para-menthane-diol, or 2-undecanone
- Wear long sleeves, long pants, and closed-toe shoes, especially during dawn and dusk when mosquitoes are most active
- Use bed nets if accommodations lack air conditioning or window screens
- Consider treating clothing and gear with permethrin
- Stay in well-screened or air-conditioned accommodations
What Travelers Should Know
There is currently no vaccine for chikungunya. Post-travel monitoring is advisable for those returning from affected areas. Symptoms typically appear 3-7 days after infection. Anyone experiencing fever and joint pain after travel should seek medical attention and inform healthcare providers of recent travel history.
Pharmacist's Note
As a pharmacist, I recommend travelers consult their healthcare provider at least 4-6 weeks before departure to discuss appropriate insect repellent options based on individual medical history and potential drug interactions. Pregnant travelers, nursing mothers, and those with sensitive skin should have tailored recommendations. Over-the-counter fever and pain management options (acetaminophen, ibuprofen) may be obtained locally if needed, but travelers should verify medication availability and customs regulations beforehand. Maintaining excellent documentation of travel dates and locations aids healthcare providers with post-travel assessment if symptoms develop.
Monitoring Your Health
Travelers should monitor their health during and after travel. If symptoms of chikungunya develop, seek prompt medical evaluation and avoid further mosquito exposure to prevent potential transmission.
For current information: Visit the CDC Travel Health Notices for the most up-to-date guidance.